Skip to the library

Reference desk

Peptide library

A useful discussion starts with a clear question. Choose an entry, read the scope beside its reference fields, and follow the sources before drawing a conclusion.

Find a starting point

Browse by reading topic

These categories organize the collection. They do not recommend a treatment or describe an approved use.

An abstract outline for browsing, not an anatomical map.
Go to the entries

Reference entries

11 of 11 entries shown

  • Semaglutide

    Product status
    Approved product
    Evidence label
    Randomized evidence
  • Tirzepatide

    Product status
    Approved product
    Evidence label
    Randomized evidence
  • Liraglutide

    Product status
    Approved product
    Evidence label
    Randomized evidence
  • Dulaglutide

    Product status
    Approved product
    Evidence label
    Randomized evidence
  • Retatrutide

    Product status
    Investigational
    Evidence label
    Randomized evidence
  • Cagrilintide

    Product status
    Investigational
    Evidence label
    Randomized evidence
  • Tesamorelin

    Product status
    Approved product
    Evidence label
    Randomized evidence
  • BPC-157

    Product status
    Not FDA-approved
    Evidence label
    Early human evidence
  • Ipamorelin

    Product status
    Not FDA-approved
    Evidence label
    Randomized evidence